EGFL6: A Potential Drug Target for Cancer and Tissue Repair (G25975)

Target Name: EGFL6

NCBI ID: G25975

EGFL6

EGFL6: A Potential Drug Target for Cancer and Tissue Repair

EGFL6 (E GFL6) is a variant of the EGF-like receptor 6 gene that is expressed in various tissues and cells of the body. One of the key functions of this receptor is its role in cell signaling, particularly in the regulation of angiogenesis, which is the process by which new blood vessels are formed.

Research has shown that EGFL6 plays a crucial role in the development and maintenance of cancer, as well as in the regulation of various physiological processes such as inflammation and tissue repair. Based on these findings, EGFL6 has been identified as a potential drug target or biomarker for a variety of diseases.

One of the key advantages of EGFL6 as a drug target is its expressed expression in a wide range of tissues and cells, including those that are difficult to target with small molecules. This makes it a more attractive target than many other genes, as it is less likely to cause off-target effects.

Additionally, EGFL6 has been shown to be involved in the regulation of angiogenesis, which is a critical process in the development of cancer. EGFL6 has been shown to promote the formation of new blood vessels, which is a key step in the process of angiogenesis.

Furthermore, EGFL6 has also been shown to play a role in the regulation of cell signaling pathways that are involved in various diseases, including cancer. For example, EGFL6 has been shown to be involved in the regulation of the PI3K/Akt signaling pathway, which is involved in the regulation of cell growth, survival, and angiogenesis.

In addition to its role in cell signaling, EGFL6 has also been shown to play a role in the regulation of tissue repair processes. This is important for the development and maintenance of tissue repair after injury or disease.

Overall, EGFL6 is a promising drug target or biomarker due to its involvement in the regulation of angiogenesis and various physiological processes. Further research is needed to fully understand its role in disease and to develop effective treatments.

Protein Name: EGF Like Domain Multiple 6

Functions: May bind integrin alpha-8/beta-1 and play a role in hair follicle morphogenesis. Promotes matrix assembly (By similarity)

The "EGFL6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EGFL6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets